Expired contract

Commercialising Scientific Advice for MHRA

Details

Supplier(s)
Deloitte LLP
Value
£98,000
Duration
3 months
Topic
Business and management consultancy services
Published
21 May 2026

Tender description

The Medicines and Healthcare Products Regulatory Agency requires consultancy to support the MHRA in responding to increasing demand, improving service quality and predictability, and ensuring the Scientific Advice offer remains competitive, sustainable, and aligned with the MHRA 2030 Strategy. The Deliverables are as follows: • Description of MHRA's unique strengths and market context; 5-10 critical hypotheses regarding potential demand and operational requirements for the MHRA to commercialise scientific advice (e.g. clinical trial advice, licensing advice, post marketing surveillance) • Synthesis and summary of 10-20 industry, expert and MHRA interviews and secondary research to define demand, likely services and their range of price points, and operational requirements for the MHRA to deliver Commercial Scientific Advice • Summary board document (presentation slide deck) that outlines core offering that is compelling, sustainable, and maintains MHRA's independent regulatory scrutiny; high level roadmap of next steps and value to MHRA. ## Contract award

Timeline

  1. Completed: Award published21 May 2026
    Current notice
  2. Completed: Award date21 May 2026
  3. Completed: Contract expiry date21 August 2026

About the buyer

The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components, buying as a central healthcare organisation with its own commercial team. Contracts Finder carries every live and forthcoming procurement opportunity. Larger competitions move to Find a Tender once they pass the high-value threshold. Suppliers register on the agency's eTendering portal with a DUNS number. A rolling commercial pipeline lists larger opportunities due over the next 18 months.

UK health spending has nearly quadrupled to £241.8bn in 2024/25, £20bn up on the year before. £140.6bn of that went to procurement, the biggest sector of UK public spending and the fastest-growing.

Over the past 5 years, most of Medicines and Healthcare products Regulatory Agency's contract awards have been in business services, IT services and laboratory and precision equipment.

Relevant CPV codes

  • 79410000 · Business and management consultancy services

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

46 similar open tenders

See more open tenders related to Commercialising Scientific Advice for MHRA.

Explore all open tenders

Related topics

Topics related to Commercialising Scientific Advice for MHRA, ranked by notice volume.

View all topics
TopicCountValue
  1. 11,460
    £1.0tn
  2. 27,610
    £1.8tn

Related buyers

Buyers similar to Medicines and Healthcare products Regulatory Agency.

View all buyers
BuyersCountValue
  1. 3,061
    £1.8bn
  2. 1,865
    £208.9bn
  3. 1,183
    £28.7bn
  4. 799
    £8.9bn
  5. 553
    £22.8bn
  6. 477
    £3.8bn
  7. 432
    £24.8m
  8. 370
    £408.9m
  9. 307
    £337.4m
  10. 295
    £1.7bn

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.